<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34685411</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1040</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life11101040</ELocationID><Abstract><AbstractText>SETD3 has been recently identified as a long sought, actin specific histidine methyltransferase that catalyzes the <i>Nτ</i>-methylation reaction of histidine 73 (H73) residue in human actin or its equivalent in other metazoans. Its homologs are widespread among multicellular eukaryotes and expressed in most mammalian tissues. SETD3 consists of a catalytic SET domain responsible for transferring the methyl group from <i>S</i>-adenosyl-L-methionine (AdoMet) to a protein substrate and a RuBisCO LSMT domain that recognizes and binds the methyl-accepting protein(s). The enzyme was initially identified as a methyltransferase that catalyzes the modification of histone H3 at K4 and K36 residues, but later studies revealed that the only bona fide substrate of SETD3 is H73, in the actin protein. The methylation of actin at H73 contributes to maintaining cytoskeleton integrity, which remains the only well characterized biological effect of SETD3. However, the discovery of numerous novel methyltransferase interactors suggests that SETD3 may regulate various biological processes, including cell cycle and apoptosis, carcinogenesis, response to hypoxic conditions, and enterovirus pathogenesis. This review summarizes the current advances in research on the SETD3 protein, its biological importance, and role in various diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Witecka</LastName><ForeName>Apolonia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7171-3222</Identifier><AffiliationInfo><Affiliation>Department of Metabolic Regulation, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwiatkowski</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Metabolic Regulation, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Takao</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3558-0880</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drozak</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3601-3845</Identifier><AffiliationInfo><Affiliation>Department of Metabolic Regulation, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UMO-2017/27/B/NZ1/00161</GrantID><Agency>Narodowe Centrum Nauki</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SETD3</Keyword><Keyword MajorTopicYN="N">actin</Keyword><Keyword MajorTopicYN="N">cytoskeleton</Keyword><Keyword MajorTopicYN="N">enteroviruses</Keyword><Keyword MajorTopicYN="N">oncogenesis</Keyword><Keyword MajorTopicYN="N">polymerization</Keyword><Keyword MajorTopicYN="N">posttranslational modifications</Keyword><Keyword MajorTopicYN="N">protein histidine methylation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34685411</ArticleId><ArticleId IdType="pmc">PMC8537074</ArticleId><ArticleId IdType="doi">10.3390/life11101040</ArticleId><ArticleId IdType="pii">life11101040</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walsh C.T., Garneau-Tsodikova S., Gatto G.J., Jr. Protein posttranslational modifications: The chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl. 2005;44:7342–7372. doi: 10.1002/anie.200501023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200501023</ArticleId><ArticleId IdType="pubmed">16267872</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke S.G. Protein methylation at the surface and buried deep: Thinking outside the histone box. Trends Biochem. Sci. 2013;38:243–252. doi: 10.1016/j.tibs.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3634909</ArticleId><ArticleId IdType="pubmed">23490039</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyman T., Schüler H., Korenbaum E., Schutt C.E., Karlsson R., Lindberg U. The role of MeH73 in actin polymerization and ATP hydrolysis. J. Mol. Biol. 2002;317:577–589. doi: 10.1006/jmbi.2002.5436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.2002.5436</ArticleId><ArticleId IdType="pubmed">11955010</ArticleId></ArticleIdList></Reference><Reference><Citation>Raftery M.J., Harrison C.A., Alewood P., Jones A., Geczy C.L. Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: Characterization of posttranslational modifications and zinc binding. Biochem. J. 1996;316:285–293. doi: 10.1042/bj3160285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3160285</ArticleId><ArticleId IdType="pmc">PMC1217336</ArticleId><ArticleId IdType="pubmed">8645219</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzinga M., Collins J.H. Amino acid sequence of a myosin fragment that contains SH-1, SH-2, and Ntau-methylhistidine. Proc. Natl. Acad. Sci. USA. 1977;74:4281–4284. doi: 10.1073/pnas.74.10.4281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.74.10.4281</ArticleId><ArticleId IdType="pmc">PMC431923</ArticleId><ArticleId IdType="pubmed">270672</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H.E., Mayr G.W. N pi-methylhistidine in myosin-light-chain kinase. Biol. Chem. Hoppe-Seyler. 1987;368:1607–1611. doi: 10.1515/bchm3.1987.368.2.1607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bchm3.1987.368.2.1607</ArticleId><ArticleId IdType="pubmed">3442604</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb K.J., Zurita-Lopez C.I., Al-Hadid Q., Laganowsky A., Young B.D., Lipson R.S., Souda P., Faull K.F., Whitelegge J.P., Clarke S.G. A novel 3-methylhistidine modification of yeast ribosomal protein Rpl3 is dependent upon the YIL110W methyltransferase. J. Biol. Chem. 2010;285:37598–37606. doi: 10.1074/jbc.M110.170787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.170787</ArticleId><ArticleId IdType="pmc">PMC2988365</ArticleId><ArticleId IdType="pubmed">20864530</ArticleId></ArticleIdList></Reference><Reference><Citation>MacTaggart B., Kashina A. Posttranslational modifications of the cytoskeleton. Cytoskeleton. 2021;78:142–173. doi: 10.1002/cm.21679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cm.21679</ArticleId><ArticleId IdType="pmc">PMC8856578</ArticleId><ArticleId IdType="pubmed">34152688</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson P., Harris C.I., Perry S.V. 3-methylhistidine in actin and other muscle proteins. Biochem. J. 1967;105:361–370. doi: 10.1042/bj1050361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj1050361</ArticleId><ArticleId IdType="pmc">PMC1198308</ArticleId><ArticleId IdType="pubmed">6056634</ArticleId></ArticleIdList></Reference><Reference><Citation>Asatoor A.M., Armstrong M.D. 3-methylhistidine, a component of actin. Biochem. Biophys. Res. Commun. 1967;26:168–174. doi: 10.1016/0006-291X(67)90229-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(67)90229-X</ArticleId><ArticleId IdType="pubmed">6067661</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzinga M. Amino acid sequence aroung 3-methylhistidine in rabbit skeletal muscle actin. Biochemistry. 1971;10:224–229. doi: 10.1021/bi00778a005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00778a005</ArticleId><ArticleId IdType="pubmed">5539224</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson P., Perry S.V. Biological activity and the 3-methylhistidine content of actin and myosin. Biochem. J. 1970;119:293–298. doi: 10.1042/bj1190293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj1190293</ArticleId><ArticleId IdType="pmc">PMC1179351</ArticleId><ArticleId IdType="pubmed">4249861</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzinga M., Collins J.H., Kuehl W.M., Adelstein R.S. Complete amino-acid sequence of actin of rabbit skeletal muscle. Proc. Natl. Acad. Sci. USA. 1973;70:2687–2691. doi: 10.1073/pnas.70.9.2687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.70.9.2687</ArticleId><ArticleId IdType="pmc">PMC427084</ArticleId><ArticleId IdType="pubmed">4517681</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayasarathy C., Rao B.S. Partial purification and characterisation of S-adenosylmethionine:protein-histidine N-methyltransferase from rabbit skeletal muscle. Biochim. Biophys. Acta. 1987;923:156–165. doi: 10.1016/0304-4165(87)90139-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-4165(87)90139-5</ArticleId><ArticleId IdType="pubmed">3801515</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan M., Lindberg U., Schutt C. The use of alternative substrates in the characterization of actin-methylating and carnosine-methylating enzymes. Eur. J. Biochem. 1992;210:311–318. doi: 10.1111/j.1432-1033.1992.tb17423.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1992.tb17423.x</ArticleId><ArticleId IdType="pubmed">1446680</ArticleId></ArticleIdList></Reference><Reference><Citation>Drozak J., Piecuch M., Poleszak O., Kozlowski P., Chrobok L., Baelde H.J., de Heer E. UPF0586 Protein C9orf41 Homolog Is Anserine-producing Methyltransferase. J. Biol. Chem. 2015;290:17190–17205. doi: 10.1074/jbc.M115.640037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.640037</ArticleId><ArticleId IdType="pmc">PMC4498059</ArticleId><ArticleId IdType="pubmed">26001783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski S., Seliga A.K., Vertommen D., Terreri M., Ishikawa T., Grabowska I., Tiebe M., Teleman A.A., Jagielski A.K., Veiga-da-Cunha M., et al. SETD3 protein is the actin-specific histidine N-methyltransferase. eLife. 2018;7:e37921. doi: 10.7554/eLife.37921.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37921</ArticleId><ArticleId IdType="pmc">PMC6289574</ArticleId><ArticleId IdType="pubmed">30526847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson A.W., Diep J., Dai S., Liu S., Ooi Y.S., Song D., Li T.M., Horton J.R., Zhang X., Liu C., et al. SETD3 is an actin histidine methyltransferase that prevents primary dystocia. Nature. 2019;565:372–376. doi: 10.1038/s41586-018-0821-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0821-8</ArticleId><ArticleId IdType="pmc">PMC6511263</ArticleId><ArticleId IdType="pubmed">30626964</ArticleId></ArticleIdList></Reference><Reference><Citation>Davydova E., Shimazu T., Schuhmacher M.K., Jakobsson M.E., Willemen H.L.D.M., Liu T., Moen A., Ho A.Y.Y., Małecki J., Schroer L., et al. The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes. Nat. Commun. 2021;12:891. doi: 10.1038/s41467-020-20670-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20670-7</ArticleId><ArticleId IdType="pmc">PMC7873184</ArticleId><ArticleId IdType="pubmed">33563959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv M., Cao D., Zhang L., Hu C., Li S., Zhang P., Zhu L., Yi X., Li C., Yang A., et al. METTL9 mediated N1-histidine methylation of zinc transporters is required for tumor growth. Protein Cell. 2021:1–6. doi: 10.1007/s13238-021-00857-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-021-00857-4</ArticleId><ArticleId IdType="pmc">PMC8674392</ArticleId><ArticleId IdType="pubmed">34218407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapell S., Jakobsson M.E. Large-scale identification of protein histidine methylation in human cells. NAR Genom. Bioinform. 2021;3:lqab045. doi: 10.1093/nargab/lqab045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nargab/lqab045</ArticleId><ArticleId IdType="pmc">PMC8140740</ArticleId><ArticleId IdType="pubmed">34046594</ArticleId></ArticleIdList></Reference><Reference><Citation>Małecki J.M., Odonohue M.F., Kim Y., Jakobsson M.E., Gessa L., Pinto R., Wu J., Davydova E., Moen A., Olsen J.V., et al. Human METTL18 is a histidine-specific methyltransferase that targets RPL3 and affects ribosome biogenesis and function. Nucleic Acids Res. 2021;49:3185–3203. doi: 10.1093/nar/gkab088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab088</ArticleId><ArticleId IdType="pmc">PMC8034639</ArticleId><ArticleId IdType="pubmed">33693809</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuura-Suzuki E., Shimazu T., Takahashi M., Kotoshiba K., Suzuki T., Kashiwagi K., Sohtome Y., Akakabe M., Sodeoka M., Dohmae N., et al. METTL18-mediated histidine methylation on RPL3 modulates translation elongation for proteostasis maintenance. bioRxiv. 2021:454307. doi: 10.1101/2021.07.29.454307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.29.454307</ArticleId><ArticleId IdType="pmc">PMC9177149</ArticleId><ArticleId IdType="pubmed">35674491</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hadid Q., Roy K., Chanfreau G., Clarke S.G. Methylation of yeast ribosomal protein Rpl3 promotes translational elongation fidelity. RNA. 2016;22:489–498. doi: 10.1261/rna.054569.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.054569.115</ArticleId><ArticleId IdType="pmc">PMC4793205</ArticleId><ArticleId IdType="pubmed">26826131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.W., Kim K.B., Kim J.Y., Seo S.B. Characterization of a novel histone H3K36 methyltransferase setd3 in zebrafish. Biosci. Biotechnol. Biochem. 2011;75:289–294. doi: 10.1271/bbb.100648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1271/bbb.100648</ArticleId><ArticleId IdType="pubmed">21307598</ArticleId></ArticleIdList></Reference><Reference><Citation>Eom G.H., Kim K.B., Kim J.H., Kim J.Y., Kim J.R., Kee H.J., Kim D.W., Choe N., Park H.J., Son H.J., et al. Histone methyltransferase SETD3 regulates muscle differentiation. J. Biol. Chem. 2011;286:34733–34742. doi: 10.1074/jbc.M110.203307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.203307</ArticleId><ArticleId IdType="pmc">PMC3186363</ArticleId><ArticleId IdType="pubmed">21832073</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S., Holt M.V., Horton J.R., Woodcock C.B., Patel A., Zhang X., Young N.L., Wilkinson A.W., Cheng X. Characterization of SETD3 methyltransferase-mediated protein methionine methylation. J. Biol. Chem. 2020;295:10901–10910. doi: 10.1074/jbc.RA120.014072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.014072</ArticleId><ArticleId IdType="pmc">PMC7415985</ArticleId><ArticleId IdType="pubmed">32503840</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzentruber J., Korshunov A., Liu X.Y., Jones D.T., Pfaff E., Jacob K., Sturm D., Fontebasso A.M., Quang D.A., Tonjes M. Driver mutations in histone H3.3 and chromatin remodeling genes in paediatric glioblastoma. Nature. 2012;482:226–231. doi: 10.1038/nature10833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10833</ArticleId><ArticleId IdType="pubmed">22286061</ArticleId></ArticleIdList></Reference><Reference><Citation>Behjati S., Tarpey P.S., Presneau N., Scheipl S., Pillay N., Van Loo P., Wedge D.C., Cooke S.L., Gundem G., Davies H., et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat. Genet. 2013;45:1479–1482. doi: 10.1038/ng.2814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2814</ArticleId><ArticleId IdType="pmc">PMC3839851</ArticleId><ArticleId IdType="pubmed">24162739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe B.R., Maxham L.A., Hamey J.J., Wilkins M.R., Partridge J.F. Histone H3 Mutations: An Updated View of Their Role in Chromatin Deregulation and Cancer. Cancers. 2019;11:660. doi: 10.3390/cancers11050660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11050660</ArticleId><ArticleId IdType="pmc">PMC6562757</ArticleId><ArticleId IdType="pubmed">31086012</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Liao S., Kwiatkowski S., Tomaka W., Yu H., Wu G., Tu X., Min J., Drozak J., Xu C. Structural insights into SETD3-mediated histidine methylation on β-actin. eLife. 2019;8:e43676. doi: 10.7554/eLife.43676.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.43676</ArticleId><ArticleId IdType="pmc">PMC6400499</ArticleId><ArticleId IdType="pubmed">30785395</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S., Horton J.R., Woodcock C.B., Wilkinson A.W., Zhang X., Gozani O., Cheng X. Structural basis for the target specificity of actin histidine methyltransferase SETD3. Nat. Commun. 2019;10:3541. doi: 10.1038/s41467-019-11554-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11554-6</ArticleId><ArticleId IdType="pmc">PMC6684798</ArticleId><ArticleId IdType="pubmed">31388018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Zhang X., Li H. Molecular basis for histidine N3-specific methylation of actin H73 by SETD3. Cell Discovery. 2020;6:3. doi: 10.1038/s41421-019-0135-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-019-0135-5</ArticleId><ArticleId IdType="pmc">PMC6971037</ArticleId><ArticleId IdType="pubmed">31993215</ArticleId></ArticleIdList></Reference><Reference><Citation>Trievel R.C., Beach B.M., Dirk L.M., Houtz R.L., Hurley J.H. Structure and catalytic mechanism of a SET domain protein methyltransferase. Cell. 2002;111:91–103. doi: 10.1016/S0092-8674(02)01000-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)01000-0</ArticleId><ArticleId IdType="pubmed">12372303</ArticleId></ArticleIdList></Reference><Reference><Citation>Trievel R.C., Flynn E.M., Houtz R.L., Hurley J.H. Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT. Nat. Struct. Biol. 2003;10:545–552. doi: 10.1038/nsb946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb946</ArticleId><ArticleId IdType="pubmed">12819771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon S.C., Zhang X., Trievel R.C., Cheng X. The SET-domain protein superfamily: Protein lysine methyltransferases. Genome Biol. 2005;6:227. doi: 10.1186/gb-2005-6-8-227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2005-6-8-227</ArticleId><ArticleId IdType="pmc">PMC1273623</ArticleId><ArticleId IdType="pubmed">16086857</ArticleId></ArticleIdList></Reference><Reference><Citation>Raunser S., Magnani R., Huang Z., Houtz R.L., Trievel R.C., Penczek P.A., Walz T. Rubisco in complex with Rubisco large subunit methyltransferase. Proc. Nat. Acad. Sci. USA. 2009;106:3160–3165. doi: 10.1073/pnas.0810563106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810563106</ArticleId><ArticleId IdType="pmc">PMC2638739</ArticleId><ArticleId IdType="pubmed">19208805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y., Levy D., Horton J.R., Peng J., Zhang X., Gozani O., Cheng X. Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling. Nucleic Acids Res. 2011;39:6380–6389. doi: 10.1093/nar/gkr256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr256</ArticleId><ArticleId IdType="pmc">PMC3159447</ArticleId><ArticleId IdType="pubmed">21515635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye S., Ding Y.F., Jia W.H., Liu X.L., Feng J.Y., Zhu Q., Cai S.L., Yang Y.S., Lu Q.Y., Huang X.T., et al. SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence. Cancer Res. 2019;79:4729–4743. doi: 10.1158/0008-5472.CAN-19-1084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-19-1084</ArticleId><ArticleId IdType="pubmed">31308046</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., Žídek A., Potapenko A., et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–589. doi: 10.1038/s41586-021-03819-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Herz H.M., Garruss A., Shilatifard A. SET for life: Biochemical activities and biological functions of SET domain-containing proteins. Trends Biochem. Sci. 2013;38:621–639. doi: 10.1016/j.tibs.2013.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2013.09.004</ArticleId><ArticleId IdType="pmc">PMC3941473</ArticleId><ArticleId IdType="pubmed">24148750</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukinović V., Casanova A.G., Roth G.S., Chuffart F., Reynoird N. Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg. Curr. Protein Pept. Sci. 2020;21:655–674. doi: 10.2174/1871527319666200102101608.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527319666200102101608</ArticleId><ArticleId IdType="pubmed">31894745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Yan C.T., Dou Y., Viboolsittiseri S.S., Wang J.H. The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis. Haematologica. 2013;98:739–743. doi: 10.3324/haematol.2012.066977.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2012.066977</ArticleId><ArticleId IdType="pmc">PMC3640118</ArticleId><ArticleId IdType="pubmed">23065515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudryashov D.S., Reisler E. ATP and ADP actin states. Biopolymers. 2013;99:245–256. doi: 10.1002/bip.22155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.22155</ArticleId><ArticleId IdType="pmc">PMC3670783</ArticleId><ArticleId IdType="pubmed">23348672</ArticleId></ArticleIdList></Reference><Reference><Citation>Stemp M.J., Guha S., Hartl F.U., Barral J.M. Efficient production of native actin upon translation in a bacterial lysate supplemented with the eukaryotic chaperonin TRiC. Biol. Chem. 2005;386:753–757. doi: 10.1515/BC.2005.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2005.088</ArticleId><ArticleId IdType="pubmed">16201870</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankel A., Brown J.I. Evaluation of kinetic data: What the numbers tell us about PRMTs. Biochim. Biophys. Acta Proteins Proteom. 2019;1867:306–316. doi: 10.1016/j.bbapap.2018.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2018.10.010</ArticleId><ArticleId IdType="pubmed">30342239</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S., Horton J.R., Wilkinson A.W., Gozani O., Zhang X., Cheng X. An engineered variant of SETD3 methyltransferase alters target specificity from histidine to lysine methylation. J. Biol. Chem. 2020;295:2582–2589. doi: 10.1074/jbc.RA119.012319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.012319</ArticleId><ArticleId IdType="pmc">PMC7049955</ArticleId><ArticleId IdType="pubmed">31911441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohn O., Feldman M., Weil L., Kublanovsky M., Levy D. Chromatin associated SETD3 negatively regulates VEGF expression. Sci. Rep. 2016;6:37115. doi: 10.1038/srep37115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep37115</ArticleId><ArticleId IdType="pmc">PMC5109252</ArticleId><ArticleId IdType="pubmed">27845446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintzen J.C.J., Moesgaard L., Kwiatkowski S., Drozak J., Kongsted J., Mecinović J. β-Actin Peptide-Based Inhibitors of Histidine Methyltransferase SETD3. Chem. Med. Chem. 2021;16:2695–2702. doi: 10.1002/cmdc.202100296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202100296</ArticleId><ArticleId IdType="pubmed">34032009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachovchin W.W., Roberts J.D. Nitrogen-15 nuclear magnetic resonance spectroscopy. The state of histidine in the catalytic triad of .alpha.-lytic protease. Implications for the charge-relay mechanism of peptide-bond cleavage by serine proteases. J. Am. Chem. Soc. 1978;100:8041–8047. doi: 10.1021/ja00494a001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja00494a001</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimsley G.R., Scholtz J.M., Pace C.N. A summary of the measured pK values of the ionizable groups in folded proteins. Protein Sci. 2009;18:247–251. doi: 10.1002/pro.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.19</ArticleId><ArticleId IdType="pmc">PMC2708032</ArticleId><ArticleId IdType="pubmed">19177368</ArticleId></ArticleIdList></Reference><Reference><Citation>Human Protein Atlas.  [(accessed on 29 July 2021)].  Available online:  https://www.proteinatlas.org/ENSG00000183576-SETD3/cell.</Citation></Reference><Reference><Citation>Sanger J.W., Wang J., Fan Y., White J., Mi-Mi L., Dube D.K., Sanger J.M., Pruyne D. Assembly and Maintenance of Myofibrils in Striated Muscle. Handb. Exp. Pharmacol. 2017;235:39–75. doi: 10.1007/164_2016_53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2016_53</ArticleId><ArticleId IdType="pubmed">27832381</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Mruk D.D., Cheng C.Y. Regulation of actin dynamics and protein trafficking during spermatogenesis—Insights into a complex process. Crit. Rev. Biochem. Mol. Biol. 2013;48:153–172. doi: 10.3109/10409238.2012.758084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10409238.2012.758084</ArticleId><ArticleId IdType="pmc">PMC3609936</ArticleId><ArticleId IdType="pubmed">23339542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sever S., Schiffer M. Actin dynamics at focal adhesions: A common endpoint and putative therapeutic target for proteinuric kidney diseases. Kidney Int. 2018;93:1298–1307. doi: 10.1016/j.kint.2017.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2017.12.028</ArticleId><ArticleId IdType="pmc">PMC5967993</ArticleId><ArticleId IdType="pubmed">29678354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X., Hao Y., Shu W., Zhao M., Zhao C., Wu Y., Peng X., Yao P., Xiao D., Qing G., et al. Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis. J. Biol. Chem. 2017;292:9022–9033. doi: 10.1074/jbc.M117.778001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.778001</ArticleId><ArticleId IdType="pmc">PMC5454089</ArticleId><ArticleId IdType="pubmed">28442573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard T.D. Actin and Actin-Binding Proteins. Cold Spring Harb. Perspect. Biol. 2016;8:a018226. doi: 10.1101/cshperspect.a018226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018226</ArticleId><ArticleId IdType="pmc">PMC4968159</ArticleId><ArticleId IdType="pubmed">26988969</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez R., Holmes K.C. Actin structure and function. Annu. Rev. Biophys. 2011;40:169–186. doi: 10.1146/annurev-biophys-042910-155359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-042910-155359</ArticleId><ArticleId IdType="pmc">PMC3130349</ArticleId><ArticleId IdType="pubmed">21314430</ArticleId></ArticleIdList></Reference><Reference><Citation>DiNubile M.J. Nucleation and elongation of actin filaments in the presence of high speed supernate from neutrophil lysates: Modulating effects of Ca2+ and phosphatidylinositol-4,5-bisphosphate. Biochim. Biophys. Acta. 1998;1405:85–98. doi: 10.1016/S0167-4889(98)00108-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4889(98)00108-6</ArticleId><ArticleId IdType="pubmed">9784614</ArticleId></ArticleIdList></Reference><Reference><Citation>Choua S.Z., Pollarda T.D. Mechanism of actin polymerization revealed by cryo-EM structures of actin filaments with three different bound nucleotides. Proc. Natl. Acad. Sci. USA. 2019;116:4265–4274. doi: 10.1073/pnas.1807028115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1807028115</ArticleId><ArticleId IdType="pmc">PMC6410863</ArticleId><ArticleId IdType="pubmed">30760599</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon L.R., Rubenstein P.A. Studies on the role of actin’s N tau-methylhistidine using oligodeoxynucleotide-directed site-specific mutagenesis. J. Biol. Chem. 1987;262:11382–11388. doi: 10.1016/S0021-9258(18)60971-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)60971-8</ArticleId><ArticleId IdType="pubmed">3301854</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep J., Ooi Y.S., Wilkinson A.W., Peters C.E., Foy E., Johnson J.R., Zengel J., Ding S., Weng K.F., Laufman O., et al. Enterovirus pathogenesis requires the host methyltransferase SETD3. Nat. Microbiol. 2019;4:2523–2537. doi: 10.1038/s41564-019-0551-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0551-1</ArticleId><ArticleId IdType="pmc">PMC6879830</ArticleId><ArticleId IdType="pubmed">31527793</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Svedin E., Kapell S., Nurminen A., Hytönen V.P., Flodström-Tullberg M. Enteroviral proteases: Structure, host interactions and pathogenicity. Rev. Med. Virol. 2016;26:251–267. doi: 10.1002/rmv.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1883</ArticleId><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser L.J., Langereis M.A., Rabouw H.H., Wahedi M., Muntjewerff E.M., de Groot R.J., van Kuppeveld F.J.M. Essential role of enterovirus 2A protease in counteracting stress granule formation and the induction of type I interferon. J. Virol. 2019;93:e00222-19. doi: 10.1128/JVI.00222-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00222-19</ArticleId><ArticleId IdType="pmc">PMC6498061</ArticleId><ArticleId IdType="pubmed">30867299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires-Luís A.S., Vieira-Coimbra M., Vieira F.Q., Costa-Pinheiro P., Silva-Santos R., Dias P.C., Antunes L., Lobo F., Oliveira J., Gonçalves C.S., et al. Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication. Epigenetics. 2015;10:1033–1043. doi: 10.1080/15592294.2015.1103578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2015.1103578</ArticleId><ArticleId IdType="pmc">PMC4844211</ArticleId><ArticleId IdType="pubmed">26488939</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Wang P., Feng X., Tang J., Li L., Zheng X., Zhang J., Hu Y., Lan T., Yuan K., et al. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma. Clin. Sci. 2019;133:2085–2105. doi: 10.1042/CS20190666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20190666</ArticleId><ArticleId IdType="pubmed">31654063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan N., Rutsch N., Győrffy B., Espinoza-Sánchez N.A., Götte M. SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. Sci. Rep. 2020;10:2262. doi: 10.1038/s41598-020-59057-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-59057-5</ArticleId><ArticleId IdType="pmc">PMC7010743</ArticleId><ArticleId IdType="pubmed">32042016</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao G.B., Li X.Z., Zeng S., Liao G.B., Li X.Z., Zeng S., Liu C., Yang S.M., Yang L., Hu C.J., et al. Regulation of the master regulator FOXM1 in cancer. Cell Commun. Signal. 2018;16:57. doi: 10.1186/s12964-018-0266-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-018-0266-6</ArticleId><ArticleId IdType="pmc">PMC6134757</ArticleId><ArticleId IdType="pubmed">30208972</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Feng X., Hao X., Wang P., Zhang Y., Zheng X., Li L., Ren S., Zhang M., Xu M. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J. Exp. Clin. Cancer Res. 2019;38:98. doi: 10.1186/s13046-019-1041-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-019-1041-2</ArticleId><ArticleId IdType="pmc">PMC6385474</ArticleId><ArticleId IdType="pubmed">30795787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Xiong W., Zhang L., Wang D., Wang Y., Wu Y., Wei F., Mo Y., Hou X., Shi L., et al. CircSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma. Oncogene. 2021;40:307–321. doi: 10.1038/s41388-020-01531-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-020-01531-5</ArticleId><ArticleId IdType="pubmed">33122825</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zhang Y., Jiang Q. SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy. Biochem. Biophys. Res. Commun. 2019;516:619–625. doi: 10.1016/j.bbrc.2019.06.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.06.058</ArticleId><ArticleId IdType="pubmed">31235251</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek J.H., Lee J., Yun H.S., Lee C.W., Song J.Y., Um H.D., Park J.K., Park I.C., Kim J.S., Kim E.H., et al. Kinesin light chain-4 depletion induces apoptosis of radioresistant cancer cells by mitochondrial dysfunction via calcium ion influx. Cell Death Dis. 2018;9:496. doi: 10.1038/s41419-018-0549-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0549-2</ArticleId><ArticleId IdType="pmc">PMC5931584</ArticleId><ArticleId IdType="pubmed">29717133</ArticleId></ArticleIdList></Reference><Reference><Citation>Abaev-Schneiderman E., Admoni-Elisha L., Levy D. SETD3 is a positive regulator of DNA-damage-induced apoptosis. Cell Death Dis. 2019;10:74. doi: 10.1038/s41419-019-1328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1328-4</ArticleId><ArticleId IdType="pmc">PMC6347638</ArticleId><ArticleId IdType="pubmed">30683849</ArticleId></ArticleIdList></Reference><Reference><Citation>Engqvist H., Parris T.Z., Kovács A., Rönnerman E.W., Sundfeldt K., Karlsson P., Helou K. Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry. Front. Oncol. 2020;10:162. doi: 10.3389/fonc.2020.00162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.00162</ArticleId><ArticleId IdType="pmc">PMC7040170</ArticleId><ArticleId IdType="pubmed">32133296</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Li T., Sun J., Liu J., Wu H. SETD3 negatively regulates VEGF expression during hypoxic pulmonary hypertension in rats. Hypertens. Res. 2018;41:691–698. doi: 10.1038/s41440-018-0068-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-018-0068-7</ArticleId><ArticleId IdType="pubmed">29950684</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao J., Luo S., Yang M., Lu Q. Overexpression of CXCR5 in CD4+ T cells of SLE patients caused by excessive SETD3. Clin. Immunol. 2020;214:108406. doi: 10.1016/j.clim.2020.108406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108406</ArticleId><ArticleId IdType="pubmed">32240818</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Cui Y., Li C., Wang Y., Cheng J., Chen S., Sun J., Ren J., Yao X., Gao J., et al. SETD3 Downregulation Mediates PTEN Upregulation-Induced Ischemic Neuronal Death Through Suppression of Actin Polymerization and Mitochondrial Function. Mol. Neurobiol. 2021:15. doi: 10.1007/s12035-021-02459-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02459-x</ArticleId><ArticleId IdType="pubmed">34218417</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza-Rodríguez M.L., Oyervides-Muñoz M.A., Pérez-Maya A.A., Sánchez-Domínguez C.N., Berlanga-Garza A., Antonio-Macedo M., Valdés-Chapa L.D., Vidal-Torres D., Vidal-Gutiérrez O., Pérez-Ibave D.C., et al. Analysis of HPV Integrations in Mexican Pre-Tumoral Cervical Lesions Reveal Centromere-Enriched Breakpoints and Abundant Unspecific HPV Regions. Int. J. Mol. Sci. 2021;22:3242. doi: 10.3390/ijms22063242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063242</ArticleId><ArticleId IdType="pmc">PMC8005155</ArticleId><ArticleId IdType="pubmed">33810183</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershey E.L., Haslett G.W., Vidali G., Allfrey V.G. Chemical studies of histone methylation. Evidence for the occurrence of 3-methylhistidine in avian erythrocyte histone fractions. J. Biol. Chem. 1969;244:4871–4877. doi: 10.1016/S0021-9258(18)94284-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)94284-5</ArticleId><ArticleId IdType="pubmed">5824561</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodcock C.B., Yu D., Zhang X., Cheng X. Human HemK2/KMT9/N6AMT1 is an active protein methyltransferase, but does not act on DNA in vitro, in the presence of Trm112. Cell Discov. 2019;5:50. doi: 10.1038/s41421-019-0119-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-019-0119-5</ArticleId><ArticleId IdType="pmc">PMC6796829</ArticleId><ArticleId IdType="pubmed">31632689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang B., Yu H., Wu G., Wan C., Liu W., Liao S., Cheng L., Zhu Z. Structural insight into HEMK2-TRMT112-mediated glutamine methylation. Biochem. J. 2020;477:3833–3838. doi: 10.1042/BCJ20200594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20200594</ArticleId><ArticleId IdType="pubmed">32969463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>